Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Orbimed Advisors LLC | 10% Owner | 2025-06-26 | 213,257 | $0.33 | $70.37kSell |
Orbimed Advisors LLC | 10% Owner | 2025-06-25 | 138,800 | $0.33 | $45.80kSell |
Orbimed Advisors LLC | 10% Owner | 2025-06-24 | 231,600 | $0.35 | $81.06kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-24 | 68,195 | $0.32 | $21.82kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-23 | 89,328 | $0.34 | $30.37kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-22 | 78,049 | $0.34 | $26.54kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-17 | 77,090 | $0.33 | $25.44kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-16 | 61,638 | $0.33 | $20.34kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-15 | 10,326 | $0.38 | $3.92kSell |
Kathleen Borthwick | CFO | 2025-02-11 | 3,183 | $0.53 | $1.69kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Advisors LLC | 19.33% | 12,013,666 | $3.98M | Insider |
Lynx1 Capital Management LP | 14.89% | 9,256,953 | $3.06M | Insider |
Lynx1 Capital Management LP | 14.89% | 9,256,953 | $3.06M | Institution |
Orbimed Advisors LLC | 11.32% | 7,034,626 | $2.33M | Institution |
Vestal Point Capital LP | 9.82% | 6,100,000 | $2.02M | Institution |
Patrick J. Heron | 8.06% | 5,009,219 | $1.66M | Insider |
Frazier Life Sciences IX LP | 8.06% | 5,009,219 | $1.66M | Insider |
Thomas Woiwode | 7.98% | 4,959,769 | $1.64M | Insider |
Versant Venture Capital VI LP | 7.98% | 4,959,769 | $1.64M | Insider |
Liam Ratcliffe | 4.21% | 2,619,430 | $867.03k | Insider |